To include your compound in the COVID-19 Resource Center, submit it here.

Nplate romiplostim regulatory update

The U.K.'s NICE issued final guidance for Nplate romiplostim from Amgen that is in line

Read the full 150 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE